Aeglea BioTherapeutics Announces Update to Corporate Structure to Increase Operational Efficiency
- Friday, January 6, 2023, 7:04
- Finance
- Add a comment
Streamlining of organization to focus on near-term deliverables for pegtarviliase in Homocystinuria and long-term value creation Cortney Caudill, M.B.A., has been promoted to the newly created role of chief product officer to increase focus and efficiency in the advancement of clinical…
About the Author
adminasapcorp has written 41552 stories on this site.